Dual therapy to treat neurological disorders

BGN Technologies, the technology-transfer company of Ben-Gurion University, has introduced a therapy for neurological disorders such as stroke and Alzheimer’s. Memantine and Losartan are combined to protect the blood-brain barrier from neurotoxic blood products.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *